Pharma Biz Can't Prove 'Ibumax' TM Can Live With Rival IP
A Finnish pharmaceutical company has failed to convince a European court that it deserves to stamp painkillers with the trademark "Ibumax-Lysin" because it would confuse shoppers already accustomed to a Polish...To view the full article, register now.
Already a subscriber? Click here to view full article